Category: Press Release - Page 219 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article MindMed Advances Phase 2 LSD Microdosing Trial For Adult ADHD, Appoints Principal Investigator

MindMed Advances Phase 2 LSD Microdosing Trial For Adult ADHD, Appoints Principal Investigator

Post published:May 11, 2020
Post category:Press Release

Read more about the article MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:May 11, 2020
Post category:Press Release

Read more about the article Champignon Announces $10,000,000 Bought Deal Private Placement

Champignon Announces $10,000,000 Bought Deal Private Placement

Post published:May 11, 2020
Post category:Press Release

Read more about the article Champignon Brands ($SHRM) Trading Halt

Champignon Brands ($SHRM) Trading Halt

Post published:May 11, 2020
Post category:Press Release

Read more about the article NewLeaf Brands Appoints Former Manager of Ebbu & Co-founder of Mydecine, Damon Michaels, as COO

NewLeaf Brands Appoints Former Manager of Ebbu & Co-founder of Mydecine, Damon Michaels, as COO

Post published:May 11, 2020
Post category:Press Release

Read more about the article Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer

Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer

Post published:May 11, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Post published:April 29, 2020
Post category:Press Release

Read more about the article Champignon Expands Preclinical Pipeline with Measured Psilocybin Dosages Studies at University of Miami

Champignon Expands Preclinical Pipeline with Measured Psilocybin Dosages Studies at University of Miami

Post published:March 27, 2020
Post category:Press Release

Read more about the article YIELD GROWTH Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Agonists from Psychedelic Mushrooms for Weight Loss

YIELD GROWTH Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Agonists from Psychedelic Mushrooms for Weight Loss

Post published:December 10, 2019
Post category:Press Release

CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

Post published:December 4, 2019
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.